
Common name
(2R)-1-allyl-2-methyl-pyrrolidine
IUPAC name
(2R)-1-allyl-2-methyl-pyrrolidine
SMILES
N1(C(CCC1)C)CC=C
Common name
(2R)-1-allyl-2-methyl-pyrrolidine
IUPAC name
(2R)-1-allyl-2-methyl-pyrrolidine
SMILES
N1(C(CCC1)C)CC=C
INCHI
InChI=1S/C8H15N/c1-3-6-9-7-4-5-8(9)2/h3,8H,1,4-7H2,2H3/t8-/m1/s1
FORMULA
C8H15N

Common name
(2R)-1-allyl-2-methyl-pyrrolidine
IUPAC name
(2R)-1-allyl-2-methyl-pyrrolidine
Molecular weight
125.211
clogP
1.746
clogS
-1.290
Frequency
0.0003
HBond Acceptor
1
HBond Donor
0
Total PolarSurface Area
3.24
Number of Rings
1
Rotatable Bond
2
Drug ID | Common name | Structure CAS | Compound class | Therapeutic area |
---|---|---|---|---|
FDBD01200 | Alizapride |
![]() |
Antiemetics; Prokinetic Agents; Alimentary Tract and Metabolism; Drugs for Functional Gastrointestinal Disorders; Propulsives; | Alizapride is used in the treatment of nausea and vomiting, including postoperative nausea and vomiting. |
1 ,
1
FRAGNAME | PDBID | SIMILIRITY | XSCORE | SMILE | HAC |
---|---|---|---|---|---|
3fh7_ligand_3_52.mol2 | 3fh7 | 0.75 | -6.78 | C[C@@H]1CCC[N@@H+]1CC | 8 |
2fxr_ligand_2_45.mol2 | 2fxr | 0.75 | -6.59 | [C@H]1(CC[NH2+]C1)CC | 7 |
2fs8_ligand_2_45.mol2 | 2fs8 | 0.75 | -6.43 | C(C)[C@@H]1CC[NH2+]C1 | 7 |
3fh7_ligand_2_22.mol2 | 3fh7 | 0.708333 | -6.47 | C[C@@H]1CCC[N@@H+]1C | 7 |
1o0d_ligand_1_1.mol2 | 1o0d | 0.708333 | -6.19 | C1[N@H+]([C@H](CC1)C)C | 7 |
2qu6_ligand_1_7.mol2 | 2qu6 | 0.708333 | -5.93 | [N@H+]1(CCC[C@H]1C)C | 7 |
4mds_ligand_1_4.mol2 | 4mds | 0.708333 | -5.78 | C[C@H]1CCC[N@@H+]1C | 7 |
1szm_ligand_1_0.mol2 | 1szm | 0.708333 | -5.67 | C[C@H]1[N@@H+](C)CCC1 | 7 |
120 ,
13